Announcements
- Study of ovarian cancer CTCs using Parsortix
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
More ▼
Key statistics
On Thursday, Angle PLC (ANPCY:QXE) closed at 2.24, 98.32% above the 52 week low of 1.13 set on Nov 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.24 |
---|---|
High | 2.24 |
Low | 2.24 |
Bid | -- |
Offer | -- |
Previous close | 2.31 |
Average volume | 2.10k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 23 2024 20:59 BST.
More ▼